Deltex Current Deferred Revenue from 2010 to 2024
| DEMG Stock | 0.08 0.01 6.67% |
Current Deferred Revenue | First Reported 2013-06-30 | Previous Quarter 44 K | Current Value 46 K | Quarterly Volatility 611.7 K |
Check Deltex Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Deltex Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 231.8 K, Interest Expense of 116 K or Total Revenue of 1.7 M, as well as many indicators such as . Deltex financial statements analysis is a perfect complement when working with Deltex Medical Valuation or Volatility modules.
Deltex | Current Deferred Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Deltex Stock Analysis
When running Deltex Medical's price analysis, check to measure Deltex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deltex Medical is operating at the current time. Most of Deltex Medical's value examination focuses on studying past and present price action to predict the probability of Deltex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deltex Medical's price. Additionally, you may evaluate how the addition of Deltex Medical to your portfolios can decrease your overall portfolio volatility.